Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Dazostinag by Takeda Pharmaceutical for Oropharyngeal Cancer: Likelihood of Approval
Dazostinag is under clinical development by Takeda Pharmaceutical and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase...
Dazostinag by Takeda Pharmaceutical for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Dazostinag is under clinical development by Takeda Pharmaceutical and currently in Phase II for Head And Neck Squamous Cell Carcinoma...
Dazostinag by Takeda Pharmaceutical for Solid Tumor: Likelihood of Approval
Dazostinag is under clinical development by Takeda Pharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
Dazostinag by Takeda Pharmaceutical for Colorectal Cancer: Likelihood of Approval
Dazostinag is under clinical development by Takeda Pharmaceutical and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...